Cresco Labs
(CNSX) CL
Cresco Labs Financials at a Glance
Market Cap
CA$467.46M
Revenue (TTM)
$638.93M
Net Income (TTM)
-$133.83M
EPS (TTM)
-CA$0.52
P/E Ratio
-2.43
Dividend
CA$0.00
Beta (Volatility)
1.26 (Average)
Dividend
CA$0.00
Beta (Volatility)
1.26 (Average)
Price
CA$1.21
Volume
151,161
Open
CA$1.27
Price
CA$1.21
Volume
151,161
Open
CA$1.27
Previous Close
CA$1.26
Daily Range
CA$1.17 - CA$1.28
52-Week Range
CA$0.60 - CA$3.12
Dividend
CA$0.00
Beta (Volatility)
1.26 (Average)
Price
CA$1.21
Volume
151,161
Open
CA$1.27
Previous Close
CA$1.26
Daily Range
CA$1.17 - CA$1.28
52-Week Range
CA$0.60 - CA$3.12
CL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cresco Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,900
CEO
Charles Bachtell
Website
www.crescolabs.comHeadquarters
Chicago, IL 60654, US
CL Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
10%
Net Income Margin
-21%
Return on Equity
-33%
Return on Capital
6%
Return on Assets
-11%
Earnings Yield
-41.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$467.46M
Shares Outstanding
371.00M
Volume
151.16K
Avg. Volume
178.03K
Financials (TTM)
Gross Profit
$324.57M
Operating Income
$76.94M
EBITDA
$20.35M
Operating Cash Flow
$74.17M
Capital Expenditure
-$35.75M
Free Cash Flow
$38.41M
Cash & ST Invst.
$90.92M
Total Debt
$583.10M
Cresco Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$148.84M
-10.2%
Gross Profit
$69.37M
-11.8%
Gross Margin
46.61%
N/A
Market Cap
CA$467.46M
N/A
Market Cap/Employee
CA$161.19K
N/A
Employees
2,900
N/A
Net Income
-$12.86M
+10.9%
EBITDA
$28.46M
-3.3%
Quarterly Fundamentals
Net Cash
-$523.58M
-6.8%
Accounts Receivable
$38.17M
-15.4%
Inventory
$108.52M
+24.9%
Long Term Debt
$563.38M
-8.1%
Short Term Debt
$23.82M
-27.3%
Return on Assets
-11.36%
N/A
Return on Invested Capital
6.05%
N/A
Free Cash Flow
-$13.05M
-155.7%
Operating Cash Flow
-$5.54M
-118.2%